288 related articles for article (PubMed ID: 31644603)
41. DCIS and axillary nodal evaluation: compliance with national guidelines.
Mitchell KB; Lin H; Shen Y; Colfry A; Kuerer H; Shaitelman SF; Babiera GV; Bedrosian I
BMC Surg; 2017 Feb; 17(1):12. PubMed ID: 28173790
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic escalation - De-escalation: Data from 15.508 early breast cancer treated with upfront surgery and sentinel lymph node biopsy (SLNB).
Houvenaeghel G; Lambaudie E; Cohen M; Classe JM; Reyal F; Garbay JR; Giard S; Chopin N; Martinez A; Rouzier R; Daraï E; Colombo PE; Coutant C; Gimbergues P; Azuar P; Villet R; Tunon de Lara C; Barranger E; Sabiani L; Goncalves A
Breast; 2017 Aug; 34():24-33. PubMed ID: 28475932
[TBL] [Abstract][Full Text] [Related]
43. Treatment of metastatic breast cancer: a large observational study on adherence to French prescribing guidelines and financial cost of the anti-HER2 antibody trastuzumab.
Poncet B; Colin C; Bachelot T; Jaisson-Hot I; Derain L; Magaud L; Fournel-Federico C; Mousseau M; Tigaud JD; Jacquin JP; Trillet-Lenoir V
Am J Clin Oncol; 2009 Aug; 32(4):369-74. PubMed ID: 19381078
[TBL] [Abstract][Full Text] [Related]
44. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
45. Breast cancer quality of care in Taiwan in relation to hospital volume: a population-based cohort study.
Ou-Yang F; Hsu NC; Juan CH; Huang HI; Moi SH; Chen FM; Liu TW; Hou MF
Asia Pac J Clin Oncol; 2015 Dec; 11(4):308-13. PubMed ID: 26264379
[TBL] [Abstract][Full Text] [Related]
46. Sentinel lymph node biopsy in two Burgundy districts: prospective multicentric study on 528 breast cancers during the year 2005.
Boulet S; Tixier H; Fraisse J; Pouget N; Causeret S; Loustalot C; Gouy S; Boichot C; Berriolo-Riedinger A; Cuisenier J
Arch Gynecol Obstet; 2010 Mar; 281(3):491-8. PubMed ID: 19554339
[TBL] [Abstract][Full Text] [Related]
47. Quality indicators in breast cancer care: An update from the EUSOMA working group.
Biganzoli L; Marotti L; Hart CD; Cataliotti L; Cutuli B; Kühn T; Mansel RE; Ponti A; Poortmans P; Regitnig P; van der Hage JA; Wengström Y; Rosselli Del Turco M
Eur J Cancer; 2017 Nov; 86():59-81. PubMed ID: 28963914
[TBL] [Abstract][Full Text] [Related]
48. Optimizing the quality of breast cancer care at certified german breast centers: a benchmarking analysis for 2003-2009 with a particular focus on the interdisciplinary specialty of radiation oncology.
Brucker SY; Wallwiener M; Kreienberg R; Jonat W; Beckmann MW; Bamberg M; Wallwiener D; Souchon R
Strahlenther Onkol; 2011 Feb; 187(2):89-99. PubMed ID: 21267530
[TBL] [Abstract][Full Text] [Related]
49. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?
Fu Y; Chung D; Cao MA; Apple S; Chang H
Ann Surg Oncol; 2014 Dec; 21(13):4109-23. PubMed ID: 25081336
[TBL] [Abstract][Full Text] [Related]
50. Does the result of completion axillary lymph node dissection influence the recommendation for adjuvant treatment in sentinel lymph node-positive patients?
Sávolt A; Polgár C; Musonda P; Mátrai Z; Rényi-Vámos F; Tóth L; Kásler M; Péley G
Clin Breast Cancer; 2013 Oct; 13(5):364-70. PubMed ID: 23773380
[TBL] [Abstract][Full Text] [Related]
51. Regional Variation in Performance for Commission on Cancer Breast Quality Measures and Impact on Overall Survival.
Kantor O; Wang CH; Yao K
Ann Surg Oncol; 2018 Oct; 25(10):3069-3075. PubMed ID: 29956092
[TBL] [Abstract][Full Text] [Related]
52. [Evaluation of the quality of the sentinel lymph node biopsy procedure in patients with breast cancer].
Pajares M; Freire JM; Moreno P; Utor A; Tocino A; Alonso E
Rev Esp Med Nucl; 2010; 29(5):236-40. PubMed ID: 20637527
[TBL] [Abstract][Full Text] [Related]
53. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
[TBL] [Abstract][Full Text] [Related]
54. The quality of care for treatment of early stage breast carcinoma: is it consistent with national guidelines?
Guadagnoli E; Shapiro CL; Weeks JC; Gurwitz JH; Borbas C; Soumerai SB
Cancer; 1998 Jul; 83(2):302-9. PubMed ID: 9669813
[TBL] [Abstract][Full Text] [Related]
55. A Population-Based Study of the Effects of a Regional Guideline for Completion Axillary Lymph Node Dissection on Axillary Surgery in Patients with Breast Cancer.
Tsao MW; Cornacchi SD; Hodgson N; Simunovic M; Thabane L; Cheng J; O'Brien MA; Strang B; Mukherjee SD; Lovrics PJ
Ann Surg Oncol; 2016 Oct; 23(10):3354-64. PubMed ID: 27342830
[TBL] [Abstract][Full Text] [Related]
56. Effect of axillary lymph node dissection after sentinel lymph node biopsy on overall survival in patients with T1 or T2 node-positive breast cancer: report from the Korean Breast Cancer Society.
Park HS; Chae BJ; Song BJ; Jung SS; Han W; Nam SJ; Youn HJ; Ko BK; Kim DW;
Ann Surg Oncol; 2014 Apr; 21(4):1231-6. PubMed ID: 24318094
[TBL] [Abstract][Full Text] [Related]
57. Patient navigation and the quality of breast cancer care: an analysis of the breast cancer care quality indicators.
Weber JJ; Mascarenhas DC; Bellin LS; Raab RE; Wong JH
Ann Surg Oncol; 2012 Oct; 19(10):3251-6. PubMed ID: 22814513
[TBL] [Abstract][Full Text] [Related]
58. Breast cancer treatment among women of different ethnicity in Hawaii.
Issell BF; Maskarinec G; Pagano I; Gotay CC
Cancer Invest; 2005; 23(6):497-504. PubMed ID: 16203657
[TBL] [Abstract][Full Text] [Related]
59. A breast center review of compliance with National Comprehensive Cancer Network Breast Cancer guidelines.
Landercasper J; Dietrich LL; Johnson JM
Am J Surg; 2006 Oct; 192(4):525-7. PubMed ID: 16978966
[TBL] [Abstract][Full Text] [Related]
60. [Compliance with the breast cancer guidelines in the region of the Comprehensive Cancer Centre South, 20031/'04].
van den Hurk CJ; van de Poll-Franse LV; Nolthenius-Puylaert MC; Roukema JA; van der Sangen MJ; Nieuwenhuijzen GA; van den Eijnden-van Raaij AJ; Coebergh JW
Ned Tijdschr Geneeskd; 2006 Apr; 150(17):963-8. PubMed ID: 17225737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
